Dear Participants On behalf of the Organizing and Program Committees, it is my distinct honor to welcome you to the 2026 KoNECT-MOHW-MFDS International Conference (KIC).

This year, we gather under the theme "Redesigning Clinical Development in a Fragmented World: From Molecule to Market." As global clinical landscapes become increasingly complex, our mission to bridge the gap between initial discovery and patient access has never been more vital. Co-hosted by the Ministry of Health and Welfare and the Ministry of Food and Drug Safety, the 2026 KIC serves as a premier platform for navigating these shifts through strategic innovation and global alignment.

Our program explores the next frontier of medicine—from oncology and GLP-1 therapies to the transformative potential of anti-aging research in obesity and dementia. We will also move beyond the hype of AI to focus on its actionable role in drug discovery, while examining how U.S. and European regulatory shifts are reshaping development strategies in Korea. By identifying winning approaches for "Molecule to Market" success, we aim to provide practical solutions for the fragmented world we operate in.

We extend our deepest gratitude to our partners and contributors for making this event possible. We hope the 2026 KIC provides a meaningful venue for fostering collaboration and advancing healthcare innovation for patients worldwide.

Welcome to the 2026 KIC.